190 related articles for article (PubMed ID: 10022884)
21. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
23. Cell replication in the arterial wall: activation of signaling pathway following in vivo injury.
Koyama H; Olson NE; Dastvan FF; Reidy MA
Circ Res; 1998 Apr; 82(6):713-21. PubMed ID: 9546380
[TBL] [Abstract][Full Text] [Related]
24. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells.
Guo YL; Baysal K; Kang B; Yang LJ; Williamson JR
J Biol Chem; 1998 Feb; 273(7):4027-34. PubMed ID: 9461593
[TBL] [Abstract][Full Text] [Related]
25. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
[TBL] [Abstract][Full Text] [Related]
26. Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1).
Shapiro PS; Ahn NG
J Biol Chem; 1998 Jan; 273(3):1788-93. PubMed ID: 9430728
[TBL] [Abstract][Full Text] [Related]
27. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid hormone-related protein induces insulin expression through activation of MAP kinase-specific phosphatase-1 that dephosphorylates c-Jun NH2-terminal kinase in pancreatic beta-cells.
Zhang B; Hosaka M; Sawada Y; Torii S; Mizutani S; Ogata M; Izumi T; Takeuchi T
Diabetes; 2003 Nov; 52(11):2720-30. PubMed ID: 14578290
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
31. The carboxyl-terminal domains of MKP-1 and MKP-2 have inhibitory effects on their phosphatase activity.
Hutter D; Chen P; Li J; Barnes J; Liu Y
Mol Cell Biochem; 2002 Apr; 233(1-2):107-17. PubMed ID: 12083364
[TBL] [Abstract][Full Text] [Related]
32. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
Durham PL; Russo AF
Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
[TBL] [Abstract][Full Text] [Related]
33. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer.
Wang HY; Cheng Z; Malbon CC
Cancer Lett; 2003 Mar; 191(2):229-37. PubMed ID: 12618338
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
[TBL] [Abstract][Full Text] [Related]
36. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells.
Schliess F; Heinrich S; Häussinger D
Arch Biochem Biophys; 1998 Mar; 351(1):35-40. PubMed ID: 9500841
[TBL] [Abstract][Full Text] [Related]
37. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1.
Sun H; Tonks NK; Bar-Sagi D
Science; 1994 Oct; 266(5183):285-8. PubMed ID: 7939666
[TBL] [Abstract][Full Text] [Related]
39. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
Zhou Y; Ling EA; Dheen ST
J Neurochem; 2007 Aug; 102(3):667-78. PubMed ID: 17403137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
